DNA demethylation of a specific region of the TSLP promoter increases the expression of TSLP in skin lesions of patients with AD and reduces the expression of filaggrin, a structural protein for which the loss-of-function mutations are associated with epidermal barrier defects and more severe AD. Here, TSLP is linked to Alzheimer disease.